Anemia, Hypochromic: Clinical Trials

26 trials for Anemia, Hypochromic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

21 completed, 3 terminated, 1 recruiting, 1 unknown. 26 Phase 1, 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 126Completed 21, Terminated 3, Recruiting 1, Unknown 1
Phase 25Completed 2, Terminated 2, Unknown 1

Follow Anemia, Hypochromic: new trials by email Literature Review of Anemia, Hypochromic trials Research Report on Anemia, Hypochromic

Trials (filtered) newest first · largest first

All 26 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Ferric Derisomaltose Injection in Chinese Participants With Iron Deficiency Anemia Under Fasting Conditions
Ferric Derisomaltose Injection, Ferric Derisomaltose Injection [MonoFer®] - Iron Deficiency Anemia
Phase 1RecruitingSichuan Huiyu Pharmaceutical Co., Ltd882026-07-232026-10-13
Four-Way Crossover Study to Compare Ferric Maltol Capsules and Oral Suspension in Healthy Volunteers
Ferric maltol capsule, Ferric maltol suspension - Anemia, Iron Deficiency
Phase 1CompletedShield Therapeutics322020-09-282025-08-24
Evaluation and Treatment of Iron Deficiency in Ovarian Cancer Patients
Iron Sucrose - Epithelial Ovarian Cancer, Anemia
Phase 1 / Phase 2TerminatedUniversity of Wisconsin, Madison92019-07-292023-01-05
Probing the Synergistic Effect of Pre-Biotics & Iron Fortificants in Anemic Subjects
Prebiotic + Iron Forificant - Iron-deficiency
Phase 1 / Phase 2CompletedUniversity of Veterinary and Animal Sciences, Lahore - Pakistan752019-04-062019-08-22
Na-GST-1/Alhydrogel With or Without CpG 10104 in Gabonese Adults
Na-GST-1, CPG 10104 - Hookworm Infection, Hookworm Disease
Phase 1CompletedBaylor College of Medicine242018-02-012021-01-13
A Study Comparing Two Ferric Carboxymaltose Formulations in Patients With Iron Deficiency Anemia
Ferric carboxymaltose - Iron Deficiency Anemia
Phase 1CompletedSandoz712017-11-292019-05-30
Lactoferrin Versus Total Dose Infusion (TDI) For Treating Iron Deficiency Anemia in Pregnancy: Role of Nursing
Oral lactoferrin, TDI of LMW iron dextran - Iron Deficiency Anemia
Phase 1 / Phase 2CompletedWoman's Health University Hospital, Egypt992017-11-012020-10-27
Evaluate the PK, Safety, Tolerability of Ferric Maltol at 3 Dosage Levels in Paediatric Subjects With Iron Deficiency
Ferric Maltol - Iron Deficiency, Anaemia in Children, Iron-Deficiency
Phase 1CompletedShield Therapeutics372017-03-142021-10-06
Dose-escalation Trial of the Safety, Pharmacokinetics, and Pharmacodynamics of Iron Isomaltoside (Monofer®)
Iron Isomaltoside - Anemia, Deficiency Diseases
Phase 1CompletedPharmacosmos A/S242017-01-062017-12-12
A Two-part Single- and Repeat-dose Study of CSJ137 in Anemic Chronic Hemodialysis Patients
CSJ137, Placebo - Anemia, Iron-Deficiency
Phase 1CompletedNovartis Pharmaceuticals402015-09-222021-10-12
Ferrous Sulphate Supplement (V0355) in Women With Iron Deficiency Anaemia
V0355 - Iron Deficiency Anemia
Phase 1TerminatedPierre Fabre Medicament292015-08-012016-09-28
Safety and Immunogenicity of Co-Administered Hookworm Vaccine Candidates Na-GST-1 and Na-APR-1 in Gabonese Adults
Na-APR-1 (M74)/Alhydrogel®, Na-GST-1/Alhydrogel®, Hepatitis B vaccine - Hookworm Infection, Hookworm Disease
Phase 1CompletedBaylor College of Medicine322014-11-012017-05-31
Safety and Immunogenicity Study of Na-GST-1 With or Without CpG
Na-GST-1/Alhydrogel®, CpG 10104 - Hookworm Infection, Hookworm Disease
Phase 1CompletedBaylor College of Medicine242014-10-012025-07-04
Pharmacokinetics, Pharmacodynamics and Safety Study of Z-213 to Iron Deficiency Anemia
Z-213 - Iron Deficiency Anemia
Phase 1CompletedZeria Pharmaceutical242014-06-012015-03-20
A Trial to Evaluate the Safety and Tolerability of a Novel Medical Food for Management of Iron Deficiency Anemia
Novel Medical Food - Iron Deficiency Anemia
Phase 1CompletedMilton S. Hershey Medical Center22014-05-012017-01-31
Safety and Immunogenicity of the Na-APR-1 Hookworm Vaccine in Healthy Adults
Na-APR-1 (M74)/Alhydrogel®, Gluco-Pyranosylphospho-Lipid A Aqueous Formulation - Hookworm Infection, Hookworm Disease
Phase 1CompletedBaylor College of Medicine402013-09-012019-07-31
Active Preoperative Anemia Management in Patients Undergoing Cardiac Surgery
EPO, Feraheme - Anemia, Cardiovascular Disease
Phase 1 / Phase 2TerminatedUniversity of Texas Southwestern Medical Center52013-04-092020-10-23
Ferrous Sulphate Supplement in Women With Iron Deficiency Anaemia
Tardyferon 80 mg - Iron Deficiency Anemia
Phase 1CompletedPierre Fabre Medicament552013-01-012014-04-15
Safety and Immunogenicity of a Human Hookworm Candidate Vaccine With Different Doses of a Novel Adjuvant
10 μg Na-GST-1/Alhydrogel, 30 μg Na-GST-1/Alhydrogel, 100 μg Na-GST-1/Alhydrogel - Hookworm Infection, Hookworm Disease
Phase 1CompletedBaylor College of Medicine402012-05-012025-01-06
Safety and Immunogenicity of a Human Hookworm Candidate Vaccine With or Without Additional Adjuvant in Brazilian Adults
10 μg Na-GST-1/Alhydrogel, 30 μg Na-GST-1/Alhydrogel, 100 μg Na-GST-1/Alhydrogel - Hookworm Infection, Hookworm Disease
Phase 1CompletedBaylor College of Medicine1022011-11-012017-05-31

Showing 20 of 26. Sign in to see all of them.

Narrower conditions

Anemia, Iron-Deficiency (26)  ·  Anemia (8)  ·  Ancylostomiasis (6)  ·  Hookworm Infections (6)  ·  Iron Deficiencies (5)  ·  Neglected Diseases (4)  ·  Carcinoma, Ovarian Epithelial (1)  ·  Cardiovascular Diseases (1)  ·  Deficiency Diseases (1)  ·  Heart Diseases (1)  ·  Hematologic Diseases (1)  ·  Hypothyroidism (1)  ·  Iron Metabolism Disorders (1)  ·  Kidney Failure, Chronic (1)  ·  Ovarian Neoplasms (1)

Broader conditions

Hemic and Lymphatic Diseases (26)  ·  Metabolic Diseases (26)  ·  Nutritional and Metabolic Diseases (26)  ·  Hematologic Diseases (25)  ·  Iron Metabolism Disorders (25)  ·  Iron Deficiencies (21)  ·  Anemia (18)  ·  Helminthiasis (6)  ·  Infections (6)  ·  Nematode Infections (6)  ·  Parasitic Diseases (6)  ·  Secernentea Infections (6)  ·  Strongylida Infections (6)  ·  Disease Attributes (5)

Interventions

Ferric Oxide, Saccharated (3)  ·  ferric maltol (2)  ·  CPG-oligonucleotide (1)  ·  D-Worm (1)  ·  Dysprosium (1)  ·  Erythropoietin (1)  ·  Ferrosoferric Oxide (1)  ·  GLA-AF adjuvant (1)  ·  Granuflex E (1)  ·  Hepatitis B Vaccines (1)  ·  Lactoferrin (1)  ·  Prebiotics (1)  ·  Sucrose (1)  ·  Thyroxine (1)  ·  Vitamin E (1)

Sponsors

Baylor College of Medicine (6)  ·  Pierre Fabre Medicament (2)  ·  Shield Therapeutics (2)  ·  Duzce University (1)  ·  International Centre for Diarrhoeal Disease Research, Bangladesh (1)  ·  Milton S. Hershey Medical Center (1)  ·  National Heart and Lung Institute (1)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)  ·  Novartis Pharmaceuticals (1)  ·  Pharmacosmos A/S (1)  ·  Sandoz (1)  ·  Sichuan Huiyu Pharmaceutical Co., Ltd (1)  ·  University of Colorado, Denver (1)  ·  University of Texas Southwestern Medical Center (1)  ·  University of Veterinary and Animal Sciences, Lahore - Pakistan (1)

Countries

United States (12)  ·  United Kingdom (3)  ·  Gabon (2)  ·  Japan (2)  ·  Romania (2)  ·  Brazil (1)  ·  Bulgaria (1)  ·  China (1)  ·  Czechia (1)  ·  Egypt (1)  ·  Israel (1)  ·  Pakistan (1)  ·  Poland (1)  ·  Puerto Rico (1)  ·  Turkey (Türkiye) (1)

Top investigators

David Diemert, MD (3)  ·  Ayola Adegnika, MD (2)  ·  David J Diemert, MD (1)  ·  Dr. Waqas Ahmad, PhD (1)  ·  Hakan Cinemre, Assit. Prof. (1)  ·  Jackie Mitchell, DPhil (1)  ·  Lisa Barroilhet, MD (1)  ·  Morteza Janghorbani, PhD (1)  ·  Nancy F Krebs, MD (1)  ·  Naomi V. Dahl, Pharm.D. (1)  ·  Philip A Poole-Wilson, MD,FRCP (1)  ·  Philip E. Greilich, MD (1)  ·  Shafiqul Alam Sarker, MD, Ph.D. (1)  ·  Warda Helmy, BSN (1)

Results publications

PMID 28464026, PMID 18191732, PMID 20876669, PMID 27548249, PMID 32926834, PMID 34597297

NIH funding

2015 (1), 2017 (1), R43DK064495 (1)